Treatment of Mild Hypertension Study: Final Results

JAMA: The Journal of the American Medical Association

Volumn 270, Issue 6, 1993, Pages 713-724

  Neaton, James D ^a   Grimm, Richard H ^a   Prineas, Ronald J ^a   Stamler, Jeremiah ^a   Grandits, Greg A ^a   Elmer, Patricia J ^a   Cutler, Jeffrey A ^a   Flack, John M ^a   Schoenberger, James A ^a   Mcdonald, Robert ^a   Lewis, Cora Elizabeth ^a   Liebson, Philip R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; AMLODIPINE; CHLORTALIDONE; CHOLESTEROL; DOXAZOSIN MESYLATE; ENALAPRIL MALEATE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BORDERLINE HYPERTENSION; CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DYSPNEA; FEMALE; HEART DEATH; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE EXTRASYSTOLE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MUSCLE DISEASE; NEUROTOXICITY; PENIS DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SKIN TOXICITY; ST SEGMENT DEPRESSION; VASCULITIS;

ACEBUTOLOL; AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; CHLORTHALIDONE; DIASTOLE; DOUBLE-BLIND METHOD; DOXAZOSIN; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENALAPRIL; EXERCISE; FEMALE; FOLLOW-UP STUDIES; HEALTH BEHAVIOR; HUMAN; HYPERTENSION; LONG-TERM CARE; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TREATMENT OUTCOME;

EID: 0027326310     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1993.03510060059034     Document Type: Article

References (83)

1. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: Results in patients with diastolic blood pressure averaging 115 through 129 mm Hg. JAMA. 1967;202:1028-1034.
2. US Public Health Service Hospitals Cooperative Study Group. Treatment of mild hypertension: Results of a ten-year intervention trial. Circ Res. 1977; 40(suppl I):1-98-1-105.
3. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program, I: Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA. 1979;242: 2562-2571.
4. Hegeland A. Treatment of mild hypertension: A five year controlled drug trial: The Oslo Study. Am J Med. 1980;69:725-732.
5. Report by the Management Committee. The Australian Therapeutic Trial in Mild Hypertension. Lancet. 1980;1:1261-1269.
6. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: Risk factor changes and mortality results. JAMA. 1982; 248:1465-1477.
7. Multiple Risk Factor Intervention Trial Research Group. Mortality after 10½ years for hypertensive participants in the Multiple Risk Factor Intervention Trial. Circulation. 1990;82:1616-1628.
8. Medical Research Council (MRC) Working Group. MRC trial of treatment of mild hypertension: Principal results. BMJ. 1985;291:97-104.
9. The IPPPSH Collaborative Group. Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: The International Prospective Primary Prevention Study in Hypertension (IPPPSH). JHypertens. 1985;3:379-392.
10. Amery A, Brixko P, Clement D, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet. 1985;1:1349-1354.
11. Wilhelmsen L, Berglund G, Elmfeldt D, et al. Beta-blockers versus diuretics in hypertensive men: Main results from the HAPPHY Trial. J Hypertens. 1987;5:561-572.
12. Wikstrand J, Warnold I, Olsson G, et al. Primary prevention with metaprolol in patients with hypertension: Mortality results from the MAPHY study. JAMA. 1988;259:1976-1982.
13. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255-3302.
14. Pauly MV. The changing health care environment. Am J Med. 1986;81(suppl 6C):3-8.
15. Stamler J, Prineas RJ, Neaton, JD et al. Blackground and design of the new US trial on diet and drug treatment of 'mild' hypertension (TOMHS). Am J Cardiol. 1987;59(suppl):51G-60G.
16. The Treatment of Mild Hypertension Research Group. The Treatment of Mild Hypertension Study. A randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. Arch Intern Med. 1991;151:1413-1423.
17. Mascioli S, Grimm RH, Neaton JD, et al. The Treatment of Mild Hypertension Study (TOMHS): Characteristics of participants at baseline. Am J Cardiol. 1990;66(suppl):32C-35C.
18. Stamler R, Stamler J, Grimm R, et al. Nutritional therapy for high blood pressure: Final report of a four-year randomized controlled trial: The Hypertension Control Program. JAMA. 1987;257:1484-1491.
19. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular Survey Methods. Geneva, Switzerland: World Health Organization; 1982:162-165.
20. Prineas RJ, Crow R, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Littleton, Mass: John Wright-PSG Inc; 1982:1-229.
21. Lipid Research Clinics Program Manual of Operations, Vol 1: Lipid and Lipoprotein Analysis. Bethesda, Md: US Dept of Health, Education, and Welfare; 1974. US Dept of Health, Education, and Welfare publication 75-628.
22. Liebson PR, Grandits G, Prineas R, et al. Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation. 1993;87:476-486.
23. Sahn DJ, DeMaria A, Kisslo J, Weyman A. The Committee on M-mode Standardization of the American Society of Echocardiography: Recommendations regarding quantifications in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-83.
24. Devereux RB, Reichek N. Echocardiographic determinations of left ventricular mass in man. Circulation. 1977;55:613-618.
25. Grandits GG, Liebson PR. Reliability of echocardiographic measurements made by trained technicians in the Treatment of Mild Hypertension Study. Circulation. 1987;76:iv-393.
26. Rautaharju PM, Maclnnis PJ, Warren JW, et al. Methodology of ECG interpretation in the Dalhousie Program: Novacode ECG classification procedures for clinical trials and population health surveys. Methods Inf Med. 1990;29:362-374.
27. Casale PN, Devereux RB, Kligfield P, et al. Electrocardiographic detection of left ventricular hypertrophy: Development and validation of improved criteria. J Am Coll Cardiol. 1985;6:572-580.
28. Casale PN, Devereux RB, Alonso DR, Campo E, Kligfield P. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: Validation with autopsy findings. Circulation. 1987;75:565-572.
29. Wolf H, Warren JW, Rautaharju PM, Milliken JA, Smith ER, Cuddy TE. An electrocardiographic mode for prediction of left ventricular mass. Proceedings of the 13th International Congress on Electrocardiography, 27th International Symposium of Vectorcardiography. September 10-12, 1986:1-2; Washington, DC.
30. Romhilt DW, Estes EH. A point score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J. 1968;75:752-758.
31. Sokolow M, Lyon TP. Ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949;37:161-186.
32. Snedecor CW, Cochran WG. Statistical Methods. Iowa City: Iowa State University Press; 1967.
33. Kaplan E, Meier P. Non-parametric estimation from incomplete observations. JAm Stat Assoc. 1958; 53:457-481.
34. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163-170.
35. Cox DR. Regression models and life tables (with discussion). J R Stat Soc. 1972;34(series B):187-220.
36. Laird NM, Ware JM. Random-effects models for longitudinal data. Biometrics. 1984;31:511-529.
37. O'Brien PC. Procedures for comparing samples with multiple endpoints. Biometrics. 1984;31:511-529.
38. The 1988 Joint National Committee. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1988;148:1023-1038.
39. Stamler R, Stamler J, Gosch FC, et al. Primary prevention of hypertension by nutritional-hygienic means: Final report of a randomized, controlled trial. JAMA. 1989;262:1801-1807.
40. Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions of blood pressure of persons with high normal levels: Results of the Trials of Hypertension Prevention, Phase I. JAMA. 1992; 267:1213-1220.
41. Wassertheil-Smoller S, Blaufox MD, Oberman AS, Langford HG, Davis BR, Wylie-Rosett J. The Trial of Antihypertensive Interventions and Management (TAIM) Study: Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension. Arch Intern Med. 1992;152: 131-136.
42. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men. N Engl J Med. 1993;328:914-921.
43. MacMahon S, Collins G, Rautaharju P, et al. Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention Trial. Am J Cardiol. 1989;63:202-210.
44. Hypertension Detection and Follow-up Program Cooperative Group. Five year findings of the Hypertension Detection and Follow-up Program. Prevention and detection of left ventricular hypertrophy and antihypertensive drug therapy. Hypertension. 1985;7:105-112.
45. Kannel WB, Gordon T, Castelli WP, Margolis JR. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease: The Framingham Study. Ann Intern Med. 1970;72:813-822.
46. Bartel A, Heyden S, Tyroler HA, Tabesh E, Cassel JC, Hames CG. Electrocardiographic predictors of coronary heart disease. Arch Intern Med. 1971; 128:929-937.
47. Kannel WB. Common electrocardiographic markers for subsequent clinical coronary events. Circulation. 1987;75(suppl II):11-25-11-27.
48. Rautaharju PM, Neaton JD. Electrocardiographic abnormalities and coronary heart disease mortality among hypertensive men in the Multiple Risk Factor Intervention Trial. Clin Invest Med. 1987;10: 606-615.
49. The 1993 Joint National Committee. The Fifth Report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-183.
50. Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering blood pressure. Lancet. 1987;1:581-584.
51. Alderman MH, Ooi WL, Madhaven S, Cohen H. Treatment-induced blood pressure reduction and risk of myocardial infarction. JAMA. 1989;262:920-924.
52. Farnett L, Mulrow CD, Linn WD, Lucey CR, Tuley MR. The J-curve phenomenon and treatment of hypertension: Is there a point beyond which pressure reduction is dangerous? JAMA. 1991;265:489-495.
53. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease, part I: Prolonged differences in blood pressure: Prospective observational studies corrected for regression dilution bias. Lancet. 1990;335:765-774.
54. Dyer AR. An analysis of the relationship of systolic blood pressure, serum cholesterol, and smoking to 14-year mortality in the Chicago Peoples Gas Company. J Chron Disease. 1975;28:571-578.
55. Reid DD, Hamilton PJS, McCartney P, Rose G. Smoking and other risk factors for coronary heart disease in British civil servants. Lancet. 1976;2:979-984.
56. Stamler J, Neaton JD, Wentworth DN. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension. 1989;13(suppl I): 2-12.
57. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: Overall findings and differences by age for 316099 white men. Arch Intern Med. 1992;152:56-64.
58. MacMahon SW, Wilchen DEL, MacDonald GJ. The effect of weight reduction on left ventricular mass. N Engl J Med. 1986;314:334-339.
59. Ferrara LA, De Simone G, Pasanisi F, Mancini M. Left ventricular mass reduction during salt depletion in arterial hypertension. Hypertension. 1984; 6:755-759.
60. Blake J, Devereux RB, Borer JS, Szulc M, Pappas TW, Laragh J. Relation of obesity, high sodium intake, and eccentric left ventricular hypertrophy to left ventricular exercise dysfunction in essential hypertension. Am J Med. 1990;88:477-485.
61. Glasser SP, Koehn DK, Powell R. Regression of left ventricular hypertrophy in treated hypertensive patients with dilevalol and metoprolol—a double blind randomized study. J Clin Pharmacol. 1989;29:791-797.
62. Schulman SP, Weiss JL, Becker LC, et al. The effects of antihypertensive therapy on left ventricular mass in elderly patients. N Engl J Med. 1990; 322:1350-1356.
63. Ofili EO, Uy ND, Castello R. Effectiveness of treatment on left ventricular mass reduction in elderly subjects with isolated systolic hypertension. Circulation. 1991;84:ii-137.
64. Gottdiener J, Reda D, Notargiacomo A, Materson B. Comparison of monotherapy effects on LV mass regression in mild-to-moderate hypertension: Difference between short and long-term therapy. J Am Coll Cardiol. 1992;19:85A.
65. Wollam GL, Hall WD, Porter VD, et al. Time course of regression of left ventricular hypertrophy in treated hypertensive patients. Am J Med. 1983; 75(suppl 3A):100-110.
66. Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients: A meta-analysis of 109 treatment studies. Am J Hypertens. 1992;5:95-110.
67. Casale PN, Devereux RB, Milner M, et al. Value of echocardiographic measurements of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med. 1986;105:173-178.
68. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991; 114:345-352.
69. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. Ann Intern Med. 1989;110:101-107.
70. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Study. N Engl J Med. 1990;322: 1561-1566.
71. Stern S, Tzivoni D. Early detection of silent ischemic heart disease by 24-hour electrocardiographic monitoring of active subjects. Br Heart J. 1974; 36:481-486.
72. Schang S, Popine C. Transient asymptomatic S-T segment depression during daily activity. Am J Cardiol. 1977;39:396-402.
73. Crawford M, Mendoza C, O'Rourke R, White DH, Boucher CA, Gorwit J. Limitations of continuous ambulatory electrocardiogram monitoring for detecting coronary artery disease. Ann Intern Med. 1978;89:1-5.
74. Deanfield J, Shea M, Ribero P, et al. Transient ST segment depression as a marker of myocardial ischemia during daily life. Am J Cardiol. 1984;54: 1195-1200.
75. Deanfield J, Shea M, Selwyn A. Clinical evaluation of transient myocardial ischemia during daily life. Am J Med. 1985;79(suppl 3A):18-24.
76. Quyyumi AA, Wright CH, Fox K. Ambulatory electrocardiographic ST segment changes in healthy volunteers. Br Heart J. 1983;50:460-464.
77. Robson DJ, Belton S. ST-segment changes in normal men during ambulatory electrocardiography. Eur Heart J. 1986;7:223-226.
78. Armstrong W, Jordan J, Morris S, McHenry PL. Prevalence and magnitude of S-T segment and T wave abnormalities in normal men during continuous electrocardiography. Am J Cardiol. 1982;49:1638-1642.
79. Hedblad B, Juul-Moller S, Svensson K, et al. Increased mortality in men with ST segment depression during 24-hour ambulatory long-term ECG recording: Results from prospective population study, 'Men Born in 1914,' from Malmo, Sweden. Eur Heart J. 1989;10:149-158.
80. Grimm RH. α1-antagonist in the treatment of hypertension. Hypertension. 1989;13(suppl):1131-1136.
81. Lehtanen JA. The effect of acebutolol on plasma lipids, blood glucose and serum insulin levels. Acta Med Scand. 1984;216:57-60.
82. Medical Research Council Working Party on Mild to Moderate Hypertension. Ventricular extrasystoles during thiazide treatment: Substudy of MRC Mild Hypertension Trial. BMJ. 1983;287:1249-1253.
83. Cohen JD, Neaton JD, Prineas RJ, Daniels KA. Diuretics, serum potassium and ventricular arrhythmias in the Multiple Risk Factor Intervention Trial. Am J Cardiol. 1987;60:548-554.